RNU6-706P

Across TCGA pan-cancer cohorts, RNU6-706P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-706P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU6-706P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-706P expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

LIHC, BRCA, and LUAD are the cancer types where RNU6-706P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.130	0.707	<.001	108	view →
BRCA	OS	Tertile	All	0.588	0.924	<.001	96	view →
LUAD	OS	Tertile	II,III,IV	0.141	0.709	<.001	36	view →
ESCA	DFS	Tertile	All	0.064	0.536	<.001	36	view →
KIRP	OS	Tertile	All	0.226	0.718	<.001	27	view →
STAD	DFS	Tertile	II,III,IV	0.298	0.699	.005	18	view →
LUSC	DFS	Tertile	II,III,IV	0.189	0.615	.005	9	view →
SKCM	DFS	Tertile	All	0.217	0.646	<.001	9	view →
BLCA	OS	Tertile	III,IV	0.769	0.351	.043	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-706P–LIHC (OS)

Open the LIHC breakdown →